Related Experiment Video
Updated: Jun 21, 2026
09:40
An Ivor Lewis Esophagectomy Designed to Minimize Anastomotic Complications and Optimize Conduit Function
Published on: April 17, 2020
Fifty-five minimally invasive Esophagectomies: a single centre experience
Sebastian F Schoppmann1, Gerhard Prager, Felix Langer
1Department of Surgery, Medical University of Vienna, A-1090 Vienna, Austria. sebastian.schoppmann@meduniwien.ac.at
Anticancer Research
|July 15, 2009
Summary
Minimally invasive esophagectomy offers an effective oncological treatment for esophageal cancer, reducing patient morbidity. This approach demonstrates feasibility and positive survival outcomes, even during the learning curve phase.
Area of Science:
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Minimally invasive esophagectomy (MIE) is an evolving alternative to open surgery.
- The goal is to provide efficient oncological therapy while minimizing surgical trauma and morbidity.
Purpose of the Study:
- To evaluate the feasibility and outcomes of minimally invasive esophagectomy for esophageal cancer.
- To assess oncological efficacy and patient morbidity rates.
Main Methods:
- Analysis of 55 consecutive minimally invasive esophagectomies.
- Inclusion of patient demographics, surgical, histopathological, and survival data.
- Calculation of surgical and non-surgical morbidity rates.
Main Results:
- 47% laparoscopic-thoracoscopic, 53% hybrid MIE procedures.
- 5.5% conversion rate to open surgery.
- Major surgical (26%) and non-surgical (13%) morbidity.
- 87% curative resection rate, 17.5 median lymph nodes.
- 1-year disease-free survival 73%, overall survival 88%.
Conclusions:
- Minimally invasive oncological resection for esophageal cancer is feasible.
- MIE has the potential to reduce postoperative morbidity.
- Enhanced oncological outcomes are achievable, even with a learning curve.
